High Content Screening and Proteomic Analysis Identify a Kinase Inhibitor That Rescues Pathological Phenotypes in a Patient-Derived Model of Parkinson’s Disease

The authors applied high content imaging on induced pluripotent stem cell-derived neurons from patients with familial Parkinson’s disease bearing the G209A α-synuclein mutation and launched a screening campaign on a small kinase inhibitor library.